Skip to contentClarengateINTELLIGENCE
Companies/14042800

Quotient Therapeutics Limited

Research and experimental development on biotechnology · London

ActiveUnited KingdomIncorporated 2022Private Limited Company
Register Ask analyst

Financial position

Accounts to 2024-12-31 · GBP · Company accounts

Net assets
£3,399,832
Cash
£814,410
Turnover
—
Profit / loss
£1,394,515
Current assets
£4,141,930
Creditors < 1 year
£1,457,811
Equity
£3,399,832
Average employees
34

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

5 periods
Reported figures2024-12-31Company2023-12-31Company2023-01-01Company2022-12-31Company2022-04-11
Balance sheet
Net assets£3,399,832£1,940,885£427,537£427,537—
Equity£3,399,832£1,940,885£427,537£427,537—
Assets
Property, plant & equipment£1,524,437£691,040—£0—
Current assets£4,141,930£2,940,131—£605,257—
Cash at bank£814,410£738,817—£438,840—
Liabilities
Creditors within one year£1,457,811£1,170,249—£177,720—
Creditors after one year£454,561£351,982—£0—
Net current assets£2,684,119£1,769,882—£427,537—
Assets less current liabilities£4,208,556£2,460,922—£427,537—
Profit & loss
Profit / loss£1,394,515£915,731—£19,955—
People
Average employees3418—30
Source evidenceView filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

1 outstanding charges
Fixed · created 2024-01-11
—
Outstanding